TumCP Cancer Research Results
TumCP, Tumor Cell proliferation: Click to Expand ⟱
| Source: |
| Type: |
Tumor cell proliferation is a key characteristic of cancer. It refers to the rapid and uncontrolled growth of cells that can lead to the formation of tumors.
|
Park, Parkinson's Disease (PD): Click to Expand ⟱
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms, and is due to the degeneration of dopaminergic neurons. It is multifactorial, caused by genetic and environmental factors and currently has no definitive cure.
-CoQ10 deficiency was observed at a higher frequency in Parkinson's disease
|
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*neuroP↑, *ROS↓, *cognitive↓, TumCP↓, TumCMig↓, TumMeta↓, angioG↓, Apoptosis↑, *Inflam↓, IL1↓, IL2↓, IL4↓, IL6↓, TNF-α↓, P53↑, Akt↓, NF-kB↓, DNAdam↑, Casp↑, COX2↓, MMP9↓, CXCR4↓, VEGF↓, *SOD↑, *Catalase↑, *GPx↑, *NRF2↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*antiOx↑, *Inflam↓, *hepatoP↑, *neuroP↑, *BioAv↓, *cardioP↑, *lipidLev↓, *RenoP↑, *TNF-α↓, *IL2↓, *PI3K↓, *Akt↓, *ROS↓, *cognitive↑, eff↑, cycD1/CCND1↓, hTERT/TERT↓, VEGF↓, p‑STAT3↓, TumMeta↓, TumCP↓, eff↑, eff↑, IL1β↓, IL6↓, NF-kB↓, ROS↑, MMP↓, Cyt‑c↑, Apoptosis↑, ER Stress↑, Ca+2↑, TET1↑, Let-7↑, Twist↓, EMT↓, TumCCA↑, Casp3↑, Casp9↑, BAX↑, HK2↓, GlucoseCon↓, lactateProd↓, Glycolysis↓, SHP1↑, N-cadherin↓, E-cadherin↑, UPR↑, PERK↑, ATF4↑, eIF2α↑, RadioS↑, NOTCH1↑, NRF2↓, BioAv↑, eff↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
*AntiDiabetic↑, *AMPK↑, *glyC↓, *ROS↓, *cardioP↑, *neuroP↑, *Half-Life↝, *toxicity↝, *BioAv↑, *glucose↓, *AGEs↓, AntiCan↑, Risk↓, TumCP↓, Apoptosis↑, TumCCA↑, cycD1/CCND1↓, pRB↓, p27↓, mTOR↓, Casp↑, ROS↑, MMP↓, ChemoSen↑, *hepatoP↑, *CRM↑, *Insulin↓,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
JAK↓, STAT↓, Inflam↓, NO↓, COX2↓, CRP↓, selectivity↑, *neuroP↑, STAT3↓, cycD1/CCND1↓, MMP2↓, STAT4↓, JAK2↓, TumCP↓, Diff↓, *eff↑, *IL6↓, *TNF-α↓, *IL1β↓, *Aβ↓,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*neuroP↑, *hepatoP↑, *cardioP↑, *Inflam↓, *antiOx↑, ChemoSen↑, eff↑, eff↑, TumCP↓, TumCCA↑, angioG↓, cycA1/CCNA1↓, cycD1/CCND1↓, cycE/CCNE↓, CDK2↓,
Showing Research Papers: 1 to 5 of 5
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
NRF2↓, 1, ROS↑, 2,
Mitochondria & Bioenergetics ⓘ
MMP↓, 2,
Core Metabolism/Glycolysis ⓘ
GlucoseCon↓, 1, Glycolysis↓, 1, HK2↓, 1, lactateProd↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 3, BAX↑, 1, Casp↑, 2, Casp3↑, 1, Casp9↑, 1, Cyt‑c↑, 1, hTERT/TERT↓, 1, p27↓, 1,
Transcription & Epigenetics ⓘ
pRB↓, 1,
Protein Folding & ER Stress ⓘ
eIF2α↑, 1, ER Stress↑, 1, PERK↑, 1, UPR↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1, P53↑, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, cycA1/CCNA1↓, 1, cycD1/CCND1↓, 4, cycE/CCNE↓, 1, TumCCA↑, 3,
Proliferation, Differentiation & Cell State ⓘ
Diff↓, 1, EMT↓, 1, Let-7↑, 1, mTOR↓, 1, NOTCH1↑, 1, SHP1↑, 1, STAT↓, 1, STAT3↓, 1, p‑STAT3↓, 1, STAT4↓, 1,
Migration ⓘ
Ca+2↑, 1, E-cadherin↑, 1, MMP2↓, 1, MMP9↓, 1, N-cadherin↓, 1, TET1↑, 1, TumCMig↓, 1, TumCP↓, 5, TumMeta↓, 2, Twist↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 2, ATF4↑, 1, NO↓, 1, VEGF↓, 2,
Immune & Inflammatory Signaling ⓘ
COX2↓, 2, CRP↓, 1, CXCR4↓, 1, IL1↓, 1, IL1β↓, 1, IL2↓, 1, IL4↓, 1, IL6↓, 2, Inflam↓, 1, JAK↓, 1, JAK2↓, 1, NF-kB↓, 2, TNF-α↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↑, 1, ChemoSen↑, 2, eff↑, 6, RadioS↑, 1, selectivity↑, 1,
Clinical Biomarkers ⓘ
CRP↓, 1, hTERT/TERT↓, 1, IL6↓, 2,
Functional Outcomes ⓘ
AntiCan↑, 1, Risk↓, 1,
Total Targets: 75
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 2, Catalase↑, 1, GPx↑, 1, NRF2↑, 1, ROS↓, 3, SOD↑, 1,
Mitochondria & Bioenergetics ⓘ
Insulin↓, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, CRM↑, 1, glucose↓, 1, glyC↓, 1, lipidLev↓, 1,
Cell Death ⓘ
Akt↓, 1,
Proliferation, Differentiation & Cell State ⓘ
PI3K↓, 1,
Immune & Inflammatory Signaling ⓘ
IL1β↓, 1, IL2↓, 1, IL6↓, 1, Inflam↓, 3, TNF-α↓, 2,
Protein Aggregation ⓘ
AGEs↓, 1, Aβ↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 1, eff↑, 1, Half-Life↝, 1,
Clinical Biomarkers ⓘ
IL6↓, 1,
Functional Outcomes ⓘ
AntiDiabetic↑, 1, cardioP↑, 3, cognitive↓, 1, cognitive↑, 1, hepatoP↑, 3, neuroP↑, 5, RenoP↑, 1, toxicity↝, 1,
Total Targets: 34
Scientific Paper Hit Count for: TumCP, Tumor Cell proliferation
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:75 Cells:% prod#:% Target#:327 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page